Loratadine for the Prevention of G-CSF-related Bone Pain

Clinical trial NCT05421416 · RECRUITING

Trial details

NCT number: NCT05421416
Sponsor: AHS Cancer Control Alberta
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Stem Cell Transplant Complications

Start date: 2024-11-28
Primary completion: 2026-12-01
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.